Hongyu Liu

Hongyu Liu

Auto-generated profile, based on publicly available information

Hongyu Liu

Shenzhen Clinical College of Stomatology, School of Stomatology, Southern Medical University, Shenzhen, Guangdong, People’s Republic of China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2022 in Biomaterials Science
Verified
Journal Article
Open access
PDF file
MHMingshu Huang
Mingshu Huang
YHYisheng Huang
Yisheng Huang
HLHongyu Liu
Hongyu Liu
ZTZhengming Tang
Zhengming Tang
YCYuanxin Chen
Yuanxin Chen
BJBo Jia
Bo Jia
Summary of applications associated with hydrogels in oral and maxillofacial regions.

1 June 2022 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
HLHongyu Liu
Hongyu Liu
YHYisheng Huang
Yisheng Huang
MHMingshu Huang
Mingshu Huang
ZHZhijie Huang
Zhijie Huang
QWQin Wang
Qin Wang
BJBo Jia
Bo Jia
Oral cancer is one of the most common cancers in the world, with more than 300,000 cases diagnosed each year, of which oral squamous cell carcinoma accounts for more than 90%, with a 5-year survival rate of only 40– 60%, and poor prognosis. Exploring new strategies for the early diagnosis and treatment of oral cancer is key to improving the survival rate. Exosomes are nanoscale lipid bilayer membrane vesicles that are secreted by almost all cell types. During the development of oral cancer, exosomes can transport their contents (DNA, RNA, proteins, etc) to target cells and promote or inhibit the proliferation, invasion, and metastasis of oral cancer cells by influencing the host immune response, drug-resistant metastasis, and tumour angiogenesis. Therefore, exosomes have great potential and advantages as biomarkers for oral cancer diagnosis, and as drug delivery vehicles or targets for oral cancer therapy. In this review, we first describe the biogenesis, biological functions, and isolation methods of exosomes, followed by their relationship with oral cancer. Here, we focused on the potential of exosomes as oral cancer biomarkers, drug carriers, and therapeutic targets. Finally, we provide an insightful discussion of the opportunities and challenges of exosome application in oral cancer diagnosis and treatment, intending to offer new ideas for the clinical management of oral cancer.

17 October 2025 in Archives of Oral Biology
Verified
Journal Article
Closed access
HLHongyu Liu
Hongyu Liu
BWBuling Wu
Buling Wu

1 December 2025 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
HLHongyu Liu
Hongyu Liu
YFYiqi Feng
Yiqi Feng
BLBinbin Lin
Binbin Lin
LZLingling Zhang
Lingling Zhang
BWBuling Wu
Buling Wu
JWJingyi Wu
Jingyi Wu
Background: Osteoporosis (OP) is one of the most common systemic bone metabolic diseases, but its specific pathogenesis remains unclear. Cystatin 3 (CST3) is a cysteine protease inhibitor involved in various physiological and pathological processes, yet its role in osteoporosis has not been clarified. This study aims to explore the diagnostic value and potential mechanism of CST3 in OP. Methods: Transcriptome data of OP patients and healthy individuals were obtained from the Gene Expression Omnibus (GEO) database. After normalization and batch effect correction, differentially expressed genes (DEGs) were screened. Gene Ontology (GO) enrichment analysis, enrichment term interaction analysis, and protein-protein interaction (PPI) analysis were performed on these DEGs. Characteristic genes were screened using Least Absolute Shrinkage and Selection Operator (LASSO) regression and Random Forest (RF) algorithms, and their diagnostic efficacy was evaluated by combining with ROC curves. A rat model of OP was constructed, and the expression of characteristic genes in bone marrow mesenchymal stem cells (BMSCs) was verified by quantitative real-time polymerase chain reaction (qRT-PCR). The functions of genes related to the characteristic genes and their potential association with immune infiltration were analyzed through co-expression analysis, PPI network, and CIBERSORT algorithm. Results: A total of 178 DEGs were screened, which were enriched in pathways such as extracellular matrix regulation and collagen metabolism. Machine learning algorithms identified CST3 and FLJ36848 as characteristic genes, with the area under the ROC curve (AUC) of both exceeding 0.9, showing excellent diagnostic efficacy. Moreover, the diagnostic efficacy of CST3 in the validation set was superior to that of FLJ36848. Animal experiments confirmed that the expression of CST3 was upregulated in BMSCs of OP rats, while the expressions of ALP and OCN were downregulated. The PPI network showed that CST3 interacted with 178 node genes. Immune infiltration analysis revealed that the infiltration proportions of M2-type macrophages, NK cells, etc. were significantly increased in the CST3 high-expression group, suggesting that CST3 may be involved in the progression of OP by regulating the immune microenvironment. Conclusion: This study found that CST3 is related to the pathogenesis of osteoporosis and may represent a promising biomarker associated with osteoporosis progression, which could be explored as a potential therapeutic target in future studies. Its potential mechanisms involve the association of CST3 with the regulation of extracellular matrix decomposition, collagen metabolism, calcium ion transmembrane transport, as well as immune cell infiltration and its function in osteoporosis. It should be clearly stated that this study still lacks direct functional evidence and verification with large-scale clinical samples. Therefore, these findings still need to be verified by more animal experiments and clinical trials, and the specific molecular mechanisms require further in-depth research.